186 related articles for article (PubMed ID: 35571047)
1.
Li X; Fan Y; Zhang Y; Wang Y; Zhao M; Tang M; Li H; Mi J; Geng Z; Wang Z; Su F
Front Genet; 2022; 13():876588. PubMed ID: 35571047
[No Abstract] [Full Text] [Related]
2. CHSY3 promotes proliferation and migration in gastric cancer and is associated with immune infiltration.
Huang X; Liu Y; Qian C; Shen Q; Wu M; Zhu B; Feng Y
J Transl Med; 2023 Jul; 21(1):474. PubMed ID: 37461041
[TBL] [Abstract][Full Text] [Related]
3. Plexin domain-containing 1 may be a biomarker of poor prognosis in hepatocellular carcinoma patients, may mediate immune evasion.
Tang MY; Shen X; Yuan RS; Li HY; Li XW; Jing YM; Zhang Y; Shen HH; Wang ZS; Zhou L; Yang YC; Wen HX; Su F
World J Gastrointest Oncol; 2024 May; 16(5):2091-2112. PubMed ID: 38764846
[TBL] [Abstract][Full Text] [Related]
4. PLXDC1 Can Be a Biomarker for Poor Prognosis and Immune Evasion in Gastric Cancer.
Li X; Fan Y; Tang M; Li H; Zhang Y; Mi J; Wang Y; Zhao M; Wang Z; Su F
J Inflamm Res; 2022; 15():5439-5455. PubMed ID: 36147688
[TBL] [Abstract][Full Text] [Related]
5. A 13-Gene Metabolic Prognostic Signature Is Associated With Clinical and Immune Features in Stomach Adenocarcinoma.
Ye Z; Zheng M; Zeng Y; Wei S; Huang H; Wang Y; Liu Q; Lin Z; Chen S; Zheng Q; Chen L
Front Oncol; 2021; 11():612952. PubMed ID: 34235071
[TBL] [Abstract][Full Text] [Related]
6. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
Han C; Zhang C; Wang H; Li K; Zhao L
BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
[TBL] [Abstract][Full Text] [Related]
7. A ferroptosis-related gene in Helicobacter pylori infection, SOCS1, serves as a potential prognostic biomarker and corresponds with tumor immune infiltration in stomach adenocarcinoma: In silico approach.
Yan P; Cheng M; Wang L; Zhao W
Int Immunopharmacol; 2023 Jun; 119():110263. PubMed ID: 37156031
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of COMMD10 as a novel prognostic biomarker for gastric cancer.
Zhao W; Lin J; Cheng S; Li H; Shu Y; Xu C
PeerJ; 2023; 11():e14645. PubMed ID: 36919165
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatics analysis of the prognostic and immunotherapeutic significance of NPRL2 in stomach adenocarcinoma.
Pi Y; Zhan Y; Song J; Jin X; Chen J
J Gastrointest Oncol; 2022 Aug; 13(4):1589-1604. PubMed ID: 36092347
[TBL] [Abstract][Full Text] [Related]
10. ASF1B acted as a prognostic biomarker for stomach adenocarcinoma.
Zhao C; Zhou J; Xing J; Yin Q
Medicine (Baltimore); 2023 Dec; 102(48):e35408. PubMed ID: 38050219
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Role of M6A-Associated Immune Genes and Cluster-Related Tumor Microenvironment Analysis: A Multi-Omics Practice in Stomach Adenocarcinoma.
Luo N; Fu M; Zhang Y; Li X; Zhu W; Yang F; Chen Z; Mei Q; Peng X; Shen L; Zhang Y; Li Q; Hu G
Front Cell Dev Biol; 2022; 10():935135. PubMed ID: 35859893
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Analysis of the Prognostic Value and Immune Function of Immune Checkpoints in Stomach Adenocarcinoma.
Shen K; Liu T
Int J Gen Med; 2021; 14():5807-5824. PubMed ID: 34557032
[TBL] [Abstract][Full Text] [Related]
13. The prognostic implications and tumor-promoting functions of CHSY3 in gastric cancer.
Wang H; Zhang J; Wei Z; Chen S; Zheng J; Li Y
Front Immunol; 2024; 15():1364979. PubMed ID: 38812506
[TBL] [Abstract][Full Text] [Related]
14. Increased
Zhaoran S; Linnebacher CS; Linnebacher M
Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046730
[TBL] [Abstract][Full Text] [Related]
15. Identification of RFX5 as prognostic biomarker and associated with immune infiltration in stomach adenocarcinoma.
Guo L; Liu D
Eur J Med Res; 2022 Aug; 27(1):164. PubMed ID: 36045400
[TBL] [Abstract][Full Text] [Related]
16. Identification of a Metabolic Reprogramming-Associated Risk Model Related to Prognosis, Immune Microenvironment, and Immunotherapy of Stomach Adenocarcinoma.
Zhao Y; Zhang D; Sun Y
J Oncol; 2022; 2022():7248572. PubMed ID: 36185624
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive Characterization of Transforming Growth Factor Beta Receptor 1 in Stomach Adenocarcinoma Identifies a Prognostic Signature for Predicting Clinical Outcomes and Immune Infiltrates.
He Y; Zhang H; Zhang Y; Wang P; Zhu K; Ba Y
Int J Gen Med; 2022; 15():3375-3391. PubMed ID: 35368798
[TBL] [Abstract][Full Text] [Related]
18. Expression and role of nuclear receptor-interacting protein 1 (NRIP1) in stomach adenocarcinoma.
Fang D; Lu G
Ann Transl Med; 2020 Oct; 8(20):1293. PubMed ID: 33209873
[TBL] [Abstract][Full Text] [Related]
19. IRF7 is a Prognostic Biomarker and Associated with Immune Infiltration in Stomach Adenocarcinoma.
Guo L; Fang T; Jiang Y; Liu D
Int J Gen Med; 2021; 14():9887-9902. PubMed ID: 34938108
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value and therapeutic potential of NEK family in stomach adenocarcinoma.
Zhou X; Nie H; Wang C; Yu X; Yang X; He X; Ou C
J Cancer; 2024; 15(10):3154-3172. PubMed ID: 38706902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
